Melanoma Research Today is a free monthly online journal that collates and summarizes the latest research about Melanoma, including details on identification, causes, prevention, treatment.

Volume 5 (2008), Issue 1 (January)

1. Anthropometric factors and risk of melanoma in women: a pooled analysis.
   Int J Cancer, 122(5): 1100-8. [Abstract] [Full-text]
2. RBP2-H1/JARID1B is a transcriptional regulator with a tumor suppressive potential in melanoma cells.
   Int J Cancer, 122(5): 1047-57. [Abstract] [Full-text]
3. Type I collagen expression contributes to angiogenesis and the development of deeply invasive cutaneous melanoma.
   Int J Cancer, 122(5): 1019-29. [Abstract] [Full-text]
4. Expression analysis of the epithelial Na+ channel delta subunit in human melanoma G-361 cells.
   Biochem Biophys Res Commun, 366(2): 489-92. [Abstract] [Full-text]
5. Subungual melanoma: management considerations.
   Am J Surg, 195(2): 244-8. [Abstract] [Full-text]
6. Clinical and molecular characterization of patients at risk for hereditary melanoma in southern Brazil.
   J Invest Dermatol, 128(2): 421-5. [Abstract] [Full-text]
7. Bim expression is reduced in human cutaneous melanomas.
   J Invest Dermatol, 128(2): 403-7. [Abstract] [Full-text]
8. Selective amplification of rare mutations using locked nucleic acid oligonucleotides that competitively inhibit primer binding to wild-type DNA.
   J Invest Dermatol, 128(2): 398-402. [Abstract] [Full-text]
9. Predictors of psychological distress among individuals with a strong family history of malignant melanoma.
   Clin Genet, 73(2): 121-31. [Abstract] [Full-text]
10. Reversal of methylation silencing of Apo2L/TRAIL receptor 1 (DR4) expression overcomes resistance of SK-MEL-3 and SK-MEL-28 melanoma cells to interferons (IFNs) or Apo2L/TRAIL.
    Oncogene, 27(4): 490-8. [Abstract] [Full-text]
11. Hyaluronan fragments induce cytokine and metalloprotease upregulation in human melanoma cells in part by signalling via TLR4.
    Exp Dermatol, 17(2): 100-7. [Abstract] [Full-text]
12. Electrochemotherapy in treatment of tumours.
    Eur J Surg Oncol, 34(2): 232-40. [Abstract] [Full-text]
13. Melanoma and squamous cell carcinoma on different nails of the same hand.
    J Am Acad Dermatol, 58(2): 323-6. [Abstract] [Full-text]
14. Traditional urinary cytology and tyrosinase RT-PCR in metastatic melanoma patients: correlation with clinical status.
    J Clin Pathol, 61(2): 179-83. [Abstract] [Full-text]
15. Methylation of CpG island promoters in uveal melanoma.
    Br J Ophthalmol, 92(2): 281-5. [Abstract] [Full-text]
16. Monitoring response to treatment in melanoma patients: potential of a serum glycomic marker.
    Int J Cancer, 122(6): 1374-83. [Abstract] [Full-text]
17. Treatment of lentigo maligna with imiquimod before staged excision.
    Dermatol Surg, 34(2): 147-51. [Abstract] [Full-text]
18. Trends in pediatric melanoma mortality in the United States, 1968 through 2004.
    Dermatol Surg, 34(2): 152-9. [Abstract] [Full-text]
19. Improved survival after lymphadenectomy for nodal metastasis from an unknown primary melanoma.
    J Clin Oncol, 26(4): 535-41. [Abstract] [Full-text]
20. Meta-analysis of phase II cooperative group trials in metastatic stage IV melanoma to determine progression-free and overall survival benchmarks for future phase II trials.
    J Clin Oncol, 26(4): 527-34. [Abstract] [Full-text]

© 2004-2008 Melanoma Research Today. All Rights Reserved.